Literature DB >> 8617720

Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells.

E Jimi1, T Ikebe, N Takahashi, M Hirata, T Suda, T Koga.   

Abstract

We investigated the NF-kappaB transcription factor in osteoclast-like cells. Osteoclast-like cells were differentiated from mouse bone marrow cells in co-culture with mouse calvaria-derived primary osteoblasts in the presence of 1alpha,25-dihydroxyvitamin D3 and prostaglandin E2 in collagen gel-coated dishes. We enriched osteoclast-like cells from the co-cultures by Pronase treatment. When the enriched osteoclast-like cells were treated with phorbol 12-myristate 13-acetate, interleukin-1 (IL-1), calcitonin, or macrophage colony-stimulating factor, only IL-1 activated an NF-kappaB-like factor, which specifically bound to a kappaB motif DNA sequence, as detected by an electrophoretic mobility shift assay. IL-1 also activated NF-kappaB induction in osteoblasts. However, the NF-kappaB-like factor induced by IL-1-stimulated osteoclast-like cells is of smaller molecular size than the factor in osteoblasts, as shown by an electrophoretic mobility shift assay. The NF-kappaB activity of osteoclast-like cells was recognized completely by antibodies against the p50 subunit, and only partially by antibodies against the p65 subunit of NF-++kappaB. Antibodies against c-Rel, Rel B, and p52 did not recognize the NF-kappaB-like factor. These results suggest that IL-1 activates an NF-kappaB-like factor in osteoclast-like cells, which contains p50 and p65-related proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617720     DOI: 10.1074/jbc.271.9.4605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture.

Authors:  K Matsushita; R Motani; T Sakuta; S Nagaoka; T Matsuyama; K Abeyama; I Maruyama; H Takada; M Torii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.

Authors:  T Sunyer; J Lewis; P Collin-Osdoby; P Osdoby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

3.  Signaling transduction analysis in gingival epithelial cells after infection with Aggregatibacter actinomycetemcomitans.

Authors:  J E Umeda; D R Demuth; E S Ando; M Faveri; M P A Mayer
Journal:  Mol Oral Microbiol       Date:  2011-11-15       Impact factor: 3.563

Review 4.  Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.

Authors:  C B Confavreux; R D Chapurlat
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

5.  Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture.

Authors:  Hiroaki Takeda; Takeshi Kikuchi; Kyoko Soboku; Iichiro Okabe; Hiroki Mizutani; Akio Mitani; Yuichi Ishihara; Toshihide Noguchi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

6.  IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

Authors:  S Kamolmatyakul; W Chen; S Yang; Y Abe; R Moroi; A M Ashique; Y-P Li
Journal:  J Dent Res       Date:  2004-10       Impact factor: 6.116

7.  Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.

Authors:  Je-Tae Woo; Makoto Kawatani; Masanori Kato; Toshimasa Shinki; Takayuki Yonezawa; Naoki Kanoh; Hiroshi Nakagawa; Masamichi Takami; Kun Hyung Lee; Paula H Stern; Kazuo Nagai; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

8.  Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival.

Authors:  Shilong Wang; Chaoliang Tang; Quan Zhang; Wenjun Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65.

Authors:  Masaaki Masuhara; Takuya Sato; Naoto Hada; Yoshiyuki Hakeda
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

Review 10.  Hormones and bone health in postmenopausal women.

Authors:  Robert Lindsay
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.